Indeed. 2015 was the time for the strategic R/S to blow Mako out of the water with an up list. Instead we changed strategy, bolstered the mid-stage pipeline and now in 2018 it is deal time. No R/S! Come on Prurisol!
Go IPIX!
(1)
(1)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.